Prygiel M, Mosiej E, Wdowiak K, Zasada A
Biomedicines. 2025; 12(12.
PMID: 39767826
PMC: 11673946.
DOI: 10.3390/biomedicines12122920.
Alremeithi R, Sullivan N, Checkeye H, Mazer-Amirshahi M, Pourmand A
Clin Exp Emerg Med. 2023; 10(2):147-156.
PMID: 36796783
PMC: 10350351.
DOI: 10.15441/ceem.22.412.
Goldberg B, Danino D, Levinsky Y, Levy I, Straussberg R, Dabaja-Younis H
Emerg Infect Dis. 2023; 29(2):235-241.
PMID: 36692296
PMC: 9881770.
DOI: 10.3201/eid2902.220991.
Beliveau M, Anderson D, Barker D, Kodihalli S, Simard E, Hall C
Clin Pharmacol Ther. 2022; 112(1):171-180.
PMID: 35467014
PMC: 9323444.
DOI: 10.1002/cpt.2620.
Mechaly A, Diamant E, Alcalay R, Ben David A, Dor E, Torgeman A
Antibodies (Basel). 2022; 11(1).
PMID: 35323195
PMC: 8944829.
DOI: 10.3390/antib11010021.
First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E.
Raja S, Guptill J, Juel V, Walter E, Cohen-Wolkowiez M, Hill H
Antimicrob Agents Chemother. 2022; 66(4):e0173221.
PMID: 35311524
PMC: 9017376.
DOI: 10.1128/aac.01732-21.
Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin B.
Guptill J, Raja S, Juel V, Walter E, Cohen-Wolkowiez M, Hill H
Antimicrob Agents Chemother. 2021; 65(7):e0232920.
PMID: 33875433
PMC: 8218613.
DOI: 10.1128/AAC.02329-20.
Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells.
Lam K, Perry K, Shoemaker C, Jin R
Toxins (Basel). 2020; 12(10).
PMID: 32992561
PMC: 7599855.
DOI: 10.3390/toxins12100616.
Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function.
Tremblay J, Vazquez-Cintron E, Lam K, Mukherjee J, Bedenice D, Ondeck C
Toxins (Basel). 2020; 12(10).
PMID: 32987745
PMC: 7598594.
DOI: 10.3390/toxins12100611.
Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product.
Anderson D, Kumar V, Arper D, Kruger E, Bilir S, Richardson J
PLoS One. 2019; 14(11):e0224700.
PMID: 31697731
PMC: 6837762.
DOI: 10.1371/journal.pone.0224700.
Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches.
Rasetti-Escargueil C, Popoff M
Toxins (Basel). 2019; 11(9).
PMID: 31547338
PMC: 6783819.
DOI: 10.3390/toxins11090528.
Designing development programs for non-traditional antibacterial agents.
Rex J, Lynch H, Cohen I, Darrow J, Outterson K
Nat Commun. 2019; 10(1):3416.
PMID: 31366924
PMC: 6668399.
DOI: 10.1038/s41467-019-11303-9.
Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model.
Torgeman A, Schwartz A, Diamant E, Baruchi T, Dor E, Ben David A
Dis Model Mech. 2018; 11(9).
PMID: 30115749
PMC: 6177009.
DOI: 10.1242/dmm.035089.
A Novel Rabbit Spirometry Model of Type E Botulism and Its Use for the Evaluation of Postsymptom Antitoxin Efficacy.
Diamant E, Pass A, Rosen O, Ben David A, Torgeman A, Barnea A
Antimicrob Agents Chemother. 2018; 62(4).
PMID: 29437616
PMC: 5913968.
DOI: 10.1128/AAC.02379-17.
Botulism mortality in the USA, 1975-2009.
Jackson K, Mahon B, Copeland J, Fagan R
Botulinum J. 2017; 3(1):6-17.
PMID: 28603554
PMC: 5460764.
DOI: 10.1504/TBJ.2015.078132.
Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations.
Torgeman A, Ozeri E, Ben David A, Diamant E, Rosen O, Schwartz A
Toxins (Basel). 2017; 9(6).
PMID: 28555060
PMC: 5488030.
DOI: 10.3390/toxins9060180.
Applying Unconventional Secretion in Ustilago maydis for the Export of Functional Nanobodies.
Terfruchte M, Reindl M, Jankowski S, Sarkari P, Feldbrugge M, Schipper K
Int J Mol Sci. 2017; 18(5).
PMID: 28468279
PMC: 5454850.
DOI: 10.3390/ijms18050937.
Septins: Regulators of Protein Stability.
Vagin O, Beenhouwer D
Front Cell Dev Biol. 2017; 4:143.
PMID: 28066764
PMC: 5168428.
DOI: 10.3389/fcell.2016.00143.
Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.
Derman Y, Selby K, Miethe S, Frenzel A, Liu Y, Rasetti-Escargueil C
Toxins (Basel). 2016; 8(9).
PMID: 27626446
PMC: 5037483.
DOI: 10.3390/toxins8090257.
Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B.
Miethe S, Mazuet C, Liu Y, Tierney R, Rasetti-Escargueil C, Avril A
PLoS One. 2016; 11(8):e0161446.
PMID: 27560688
PMC: 4999263.
DOI: 10.1371/journal.pone.0161446.
